Streetbeat News

Analyst Ratings

KA

Kineta, Inc. (NASDAQ:KA) announced that two abstracts on its immuno-oncology therapies have been accepted for poster presentation at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting. The presentations will include new clinical data on KVA12123, Kineta's VISTA blocking immunotherapy, and new preclinical data on its anti-CD27 agonist antibody program. Following the announcement, Kineta's shares were halted on a circuit breaker to the upside.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:21 pm

LAZ

Morgan Stanley analyst Ryan Kenny has maintained an Overweight rating on Lazard (NYSE:LAZ) but lowered the price target from $42 to $41.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:18 pm

LLY

A significant number of investors have taken a bearish stance on Eli Lilly (NYSE:LLY), with 53% of detected trades showing bearish expectations. Whales have been targeting a price range from $160.0 to $800.0 for Eli Lilly over the last 3 months. The price of LLY is up 0.99% at $611.25. Morgan Stanley, Cantor Fitzgerald, and Wells Fargo have maintained their Overweight rating on Eli Lilly, with price targets of $673, $630, and $650 respectively.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:17 pm

NFLX

A significant bullish stance on Netflix (NASDAQ:NFLX) has been observed through unusual options activity. The sentiment among these big-money traders is split between 56% bullish and 43% bearish. The whales have been targeting a price range from $300.0 to $1275.0 for Netflix over the last 3 months. The current price of NFLX is down -0.22% at $365.11. Analysts have mixed ratings on Netflix with price targets ranging from $293 to $525.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:17 pm

BTCUSD

Crypto analyst Benjamin Cowen predicts a potential downturn for Bitcoin (CRYPTO: BTC) to a target of $23,000. This comes amid concerns about Bitcoin's recent lows around the $25,000 mark. Cowen suggests that surpassing these lows could severely impact the altcoin market. He also hinted at a potential topping pattern for Bitcoin's current market behavior.

Portfolio Pulse from Murtuza Merchant

October 12, 2023 | 2:11 pm

BYND

Beyond Meat's stock has been downgraded from Neutral to Underperform by Mizuho, leading to a decrease in the company's shares.

Portfolio Pulse from Bill Haddad

October 12, 2023 | 2:10 pm

KDP

Bernstein has maintained an Outperform rating on Keurig Dr Pepper but lowered its price target from $40 to $37. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:10 pm

F

MSFT

NOC

NVDA

QCOM

TSLA

The article covers a range of topics including Microsoft's appeal against a $29B US tax claim by the IRS, insider selling of Qualcomm and Northrop Grumman stocks, and Nvidia's bullish outlook with a predicted 50% stock gain. It also mentions Tesla's warning about the potential slashing of Model 3's tax credit and Ford's ongoing UAW strike. In the crypto space, Bitcoin, Ethereum, and Dogecoin are discussed.

Portfolio Pulse from Akanksha Bakshi

October 12, 2023 | 2:06 pm

RMD

ResMed (NYSE:RMD) has received a mix of bullish and indifferent analyst ratings in the last quarter, with no bearish ratings. The average price target is $231.3, indicating potential upside from the current price of $141.0. However, this average has decreased by 13.08% from the previous target of $266.12.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:00 pm

SHOP

Shopify (NYSE:SHOP) has received various analyst ratings in the last quarter, with 4 bullish, 6 somewhat bullish, and 12 indifferent. The average price target is $66.91, indicating an upside from the current price of $53.66. This average has increased by 9.44% from the previous average price target of $61.14.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:00 pm